DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Esidrix (Hydrochlorothiazide) - Adverse Event Reports - Life Threatening Events

 



Index of reports > Cases resulting in life threatening events (14)

     Loss of Consciousness (10)Stevens-Johnson Syndrome (8)Fall (6)Sjogren's Syndrome (6)Renal Failure Acute (6)Hyponatraemia (5)Staphylococcal Sepsis (5)Blood Creatinine Increased (5)Asthenia (5)Rash Erythematous (4)

Below is the selection of adverse event reports related to Esidrix (Hydrochlorothiazide) that includes cases resulting in life threatening events.

Adverse event in 69 year old male receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from Norway on 2007-10-17

Patient: 69 year old male

Adverse reactions / side effects: Abdominal Pain, Drug Interaction, Lactic Acidosis, Hyperventilation, Nephrolithiasis, Renal Failure, Catheter Placement, Diarrhoea, Visual Disturbance, Circulatory Collapse, Respiratory Arrest, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Losartan Potassium
    Dosage: 50 mg, unk
    Indication: Hypertension

Metformin HCL
    Indication: Type 2 Diabetes Mellitus

Esidrix
    Dosage: 12.5 mg, unk
    Indication: Hypertension



Adverse event in 69 year old male receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from Norway on 2007-10-16

Patient: 69 year old male

Adverse reactions / side effects: Abdominal Pain, Drug Interaction, Lactic Acidosis, Hyperventilation, Nephrolithiasis, Renal Failure, Catheter Placement, Diarrhoea, Visual Disturbance, Circulatory Collapse, Respiratory Arrest, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Losartan Potassium
    Dosage: 50 mg, unk
    Indication: Hypertension

Metformin
    Indication: Type 2 Diabetes Mellitus

Esidrix
    Dosage: 12.5 mg, unk
    Indication: Hypertension



Adverse event in 49 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a health professional (non-physician/pharmacist) from Norway on 2007-10-15

Patient: 49 year old female

Adverse reactions / side effects: Metabolic Acidosis, Hypothermia, Hypoglycaemia, Drug Interaction, Lactic Acidosis, Accidental Overdose, Haemodialysis, Blood Lactic Acid Increased, Loss of Consciousness, Hyperventilation, Drug Toxicity, Respiratory Failure, Circulatory Collapse, Gastroenteritis, Renal Failure Acute

Adverse event resulted in: life threatening event

Suspect drug(s):
Losartan Potassium
    Dosage: 50 mg, unk
    Indication: Hypertension

Metformin
    Dosage: 6 g/day
    Administration route: Oral

Esidrix
    Dosage: 12.5 mg, unk
    Indication: Hypertension

Other drugs received by patient: Glibenklamid



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a physician from France on 2007-07-09

Patient: 79 year old female

Adverse reactions / side effects: General Physical Condition Abnormal, Lupus-Like Syndrome, Fall, Periorbital Haematoma, Loss of Consciousness, Proteinuria, Depression, Sjogren's Syndrome, Renal Failure Acute, Prurigo, Stevens-Johnson Syndrome, White Blood Cell Count Decreased, Biopsy Salivary Gland Abnormal, Hyponatraemia, Staphylococcal Sepsis, Antinuclear Antibody Positive, Conjunctivitis Infective, Rash Erythematous, Dehydration, Asthenia, Anti-SS-A Antibody Positive, Face Injury

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Desloratadine
    Dosage: 5 mg; qd; po
    Administration route: Oral
    Start date: 2006-06-15
    End date: 2006-06-19

Arcalion (NO Pref. Name)
    Dosage: po
    Administration route: Oral
    Start date: 2006-06-01
    End date: 2006-06-19

Esidrix
    End date: 2006-06-19

Primperan TAB
    End date: 2006-06-19

Fluconazole
    End date: 2006-06-19



Adverse event in 65 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from France on 2007-05-31

Patient: 65 year old female, weighing 51.0 kg (112.2 pounds)

Adverse reactions / side effects: Nausea, Hyponatraemia, Condition Aggravated, Hypokalaemia, Loss of Consciousness, Renal Impairment, Malaise, Anorexia, Bradycardia, Blood Creatinine Increased, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Esidrix (Hydrochlorothiazide)

Other drugs received by patient: Lasix; Cellcept; Cortancyl; Cardensiel; Triatec; Cozaar; Levothyroxine Sodium; Mediator; Omeprazole; Plavix; Fosamax; Prograf; DI-Antalvic; Noroxin; Insulin



Adverse event in 65 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from France on 2007-05-31

Patient: 65 year old female, weighing 51.0 kg (112.2 pounds)

Adverse reactions / side effects: Nausea, Hyponatraemia, Condition Aggravated, Hypokalaemia, Loss of Consciousness, Renal Impairment, Malaise, Anorexia, Bradycardia, Blood Creatinine Increased, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Esidrix (Hydrochlorothiazide)

Other drugs received by patient: Lasix; Cellcept; Cortancyl; Cardensiel; Triatec; Cozaar; Levothyroxine Sodium; Mediator; Omeprazole; Plavix; Fosamax; Prograf; DI-Antalvic; Noroxin; Insulin



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from France on 2007-05-29

Patient: 79 year old female

Adverse reactions / side effects: Pruritus, Lupus-Like Syndrome, Conjunctivitis, Pyrexia, Hypernatraemia, Fall, Loss of Consciousness, Periorbital Haematoma, C-Reactive Protein Increased, Proteinuria, Blood Uric Acid Increased, Dermatitis Bullous, Injury, Erythema Multiforme, Sjogren's Syndrome, Renal Failure Acute, Stevens-Johnson Syndrome, General Physical Health Deterioration, Staphylococcal Sepsis, Epidermolysis, Antinuclear Antibody Positive, Fluid Replacement, Dehydration, Rash Erythematous, Toxic Skin Eruption, Anti-SS-A Antibody Positive, Inflammation

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Arcalion
    Dosage: unk, unk
    Administration route: Oral
    Indication: Depressive Symptom
    Start date: 2006-06-01
    End date: 2006-06-19

Primperan INJ
    End date: 2006-06-19

Triflucan
    End date: 2006-06-19

Desloratadine
    Dosage: 1 df, qd
    Administration route: Oral
    Start date: 2006-06-15
    End date: 2006-06-19

Esidrix
    Dosage: unk, unk
    Administration route: Oral
    End date: 2006-06-19



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a health professional (non-physician/pharmacist) from France on 2007-05-04

Patient: 79 year old female

Adverse reactions / side effects: Sepsis, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event

Suspect drug(s):
Triflucan
    Start date: 2006-06-16
    End date: 2006-06-19

Arcalion
    Administration route: Oral
    Start date: 2006-06-01
    End date: 2006-06-19

Primperan INJ
    Start date: 2006-06-19
    End date: 2006-06-19

Desloratadine
    Administration route: Oral
    Start date: 2006-06-15
    End date: 2006-06-19

Esidrix



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a physician from France on 2007-05-04

Patient: 79 year old female

Adverse reactions / side effects: Fall, Loss of Consciousness, Proteinuria, Blood Uric Acid Increased, Eyelid Disorder, Depression, Sjogren's Syndrome, Erythema Multiforme, Haematoma, Renal Failure Acute, Stevens-Johnson Syndrome, White Blood Cell Count Decreased, Toxic Epidermal Necrolysis, Hyponatraemia, Staphylococcal Sepsis, Epidermolysis, Antinuclear Antibody Positive, Conjunctivitis Infective, Sialoadenitis, Dehydration, Asthenia, Anti-SS-A Antibody Positive, Face Injury, Toxic Skin Eruption

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Desloratadine
    Dosage: 5 mg; qd; po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-06-15
    End date: 2006-06-19

Arcalion (NO Pref. Name)
    Dosage: po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2006-06-01
    End date: 2006-06-19

Esidrix
    Indication: Drug USE FOR Unknown Indication
    End date: 2006-06-19

Primperan TAB
    Indication: Drug USE FOR Unknown Indication
    End date: 2006-06-19

Fluconazole
    Indication: Drug USE FOR Unknown Indication



Adverse event in 65 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from France on 2007-04-20

Patient: 65 year old female, weighing 51.0 kg (112.2 pounds)

Adverse reactions / side effects: Nausea, Hyponatraemia, Hypokalaemia, Loss of Consciousness, Renal Impairment, Malaise, Anorexia, Bradycardia, Asthenia, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Esidrix (Hydrochlorothiazide)

Other drugs received by patient: Lasix; Cellcept; Cortancyl; Cardensiel; Triatec; Cozaar; Levothyroxine Sodium; Mediator; Omeprazole; Plavix; Fosamax; Prograf; DI-Antalvic; Noroxin; Insulin



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from France on 2007-04-11

Patient: 79 year old female

Adverse reactions / side effects: Pruritus, Lupus-Like Syndrome, Sodium Retention, Staphylococcal Sepsis, Fall, Loss of Consciousness, Proteinuria, Rash Erythematous, Dermatitis Bullous, Injury, Sjogren's Syndrome, Toxic Skin Eruption, Renal Failure Acute, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Arcalion
    Dosage: unk, unk
    Administration route: Oral
    Start date: 2006-05-01

Primperan INJ

Triflucan

Desloratadine

Esidrix
    Administration route: Oral



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a health professional (non-physician/pharmacist) from France on 2007-04-11

Patient: 79 year old female

Adverse reactions / side effects: Sepsis, Staphylococcal Sepsis, Stevens-Johnson Syndrome, Renal Failure Acute

Adverse event resulted in: life threatening event

Suspect drug(s):
Triflucan

Arcalion
    Administration route: Oral

Primperan INJ

Desloratadine

Esidrix



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a individual with unspecified qualification from France on 2007-03-09

Patient: 79 year old female

Adverse reactions / side effects: Pruritus, Lupus-Like Syndrome, Fall, Loss of Consciousness, Rash Erythematous, Dermatitis Bullous, Injury, Sjogren's Syndrome, Toxic Skin Eruption, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Arcalion
    Dosage: unk, unk
    Administration route: Oral
    Start date: 2006-05-01

Primperan INJ

Triflucan

Desloratadine

Esidrix
    Administration route: Oral



Adverse event in 79 year old female receiving Esidrix (Hydrochlorothiazide)

Reported by a physician from France on 2007-03-05

Patient: 79 year old female

Adverse reactions / side effects: Systemic Lupus Erythematosus, Sjogren's Syndrome, Fall, Face Injury, Loss of Consciousness, Stevens-Johnson Syndrome

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Desloratadine
    Dosage: po
    Administration route: Oral

Arcalion (NO Pref. Name)
    Dosage: po
    Administration route: Oral

Esidrix

Primperan TAB

Trifulcan (Fluconazole)
    Indication: Drug USE FOR Unknown Indication

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009